Theravance Biopharma, Inc. (TBPH)
20.01
-0.10
(-0.50%)
USD |
NASDAQ |
Jan 16, 16:00
20.98
+0.97
(+4.85%)
After-Hours: 20:00
Theravance Biopharma Total Assets (Quarterly): 415.46M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Perspective Therapeutics, Inc. | 294.82M |
| Skye Bioscience, Inc. | 41.32M |
| Kyntra Bio, Inc. | 137.01M |
| Myomo, Inc. | 34.08M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 182.78M |
| Shareholders Equity (Quarterly) | 232.68M |
| Debt to Equity Ratio | 0.1917 |
| Current Ratio | 9.482 |
| Net Debt Paydown Yield | 0.06% |